Worth Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Worth Asset Management's LLY Position: Q2 2026 in Review
Worth Asset Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $24.5K and bringing the position to 1,633 shares worth $1.96M. The position accounts for 0.63% of the portfolio, ranked #30.
Worth Asset Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.9M in Q4 2025. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Worth Asset Management held 1,633 shares of Eli Lilly worth $1.96M as of Q2 2026.
- Worth Asset Management bought 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
- Eli Lilly made up 0.63% of Worth Asset Management's portfolio in Q2 2026, its #30 holding.
- Worth Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- Worth Asset Management's Eli Lilly position peaked at $2.9M in Q4 2025.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.